{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:20:04Z","timestamp":1792801204952,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Innovations Research Special Key Project of Shanghai \u2018Science and Technology Innovation Action Plan\u2019","award":["21Y21901100"],"award-info":[{"award-number":["21Y21901100"]}]},{"name":"Key Project of the National Natural Science Foundation of China","award":["No. 82030050"],"award-info":[{"award-number":["No. 82030050"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a progressive, neurodegenerative illness marked by the loss of dopaminergic neurons, causing motor symptoms. Oral levodopa replacement therapy remains the gold standard in the treatment of PD. It is, nevertheless, a symptomatic treatment. There is currently no effective treatment for PD. Therefore, new therapies for PD are highly desirable. Low-intensity pulsed ultrasound (LIPUS) has been shown to improve behavioral functions in PD animal models. It is a new type of neuromodulation approach that combines noninvasiveness with high spatial precision. The purpose of this study is to establish a new clinical protocol for LIPUS in the treatment of movement disorders in patients with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This protocol is a single-site, prospective, double-blind, randomized controlled trial (RCT). Forty-eight participants with clinically confirmed PD will be randomly allocated to one of two groups: LIPUS group or sham group. All of the participants continue to use pharmacological therapy as a fundamental treatment. The primary outcome is the difference between groups from baseline to 4\u00a0months in the change in the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) motor score (part III). The secondary outcomes include the rating scales such as the Mini-Mental State Examination (MMSE), and other three rating scales, and medical examinations including high-density electroencephalography (hdEEG) and functional magnetic resonance imaging (fMRI). The primary safety outcome will be assessed at 4\u00a0months, and adverse events will be recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study represents the clinical investigation into the efficacy of therapeutic LIPUS in the treatment of PD for the first time. If LIPUS is determined to be effective, it could offer a practical and innovative means of expanding the accessibility of ultrasound therapy by using a wearable LIPUS device within a home setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Registry ChiCTR2100052093. Registered on 17 October 2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-024-08092-y","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T08:02:14Z","timestamp":1713772934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of Wearable low-intensity pulsed Ultrasound treatment in the Movement disorder in Parkinson\u2019s disease (the SWUMP trial): protocol for a single-site, double-blind, randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuanyu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"issue":"6","key":"8092_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"issue":"13","key":"8092_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, et al. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390.","journal-title":"Mov Disord"},{"issue":"12","key":"8092_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"11","key":"8092_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson's Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol."},{"issue":"8","key":"8092_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna). 2017;124(8):901\u20135.","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"8092_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox SH, Katzenschlager R, Lim SY, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord. 2018;33(8):1248\u201366.","journal-title":"Mov Disord"},{"issue":"16","key":"8092_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670\u201383.","journal-title":"JAMA"},{"issue":"16","key":"8092_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMct1208070","volume":"367","author":"MS Okun","year":"2012","unstructured":"Okun MS. Deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med. 2012;367(16):1529\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"8092_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mds.26890","volume":"32","author":"P Krack","year":"2017","unstructured":"Krack P, Martinez-Fernandez R, Del Alamo M, et al. Current applications and limitations of surgical treatments for movement disorders. Mov Disord. 2017;32(1):36\u201352.","journal-title":"Mov Disord"},{"issue":"10","key":"8092_CR10","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1109\/TBME.2018.2889669","volume":"66","author":"X Jiang","year":"2019","unstructured":"Jiang X, Savchenko O, Li Y, et al. A review of low-intensity pulsed ultrasound for therapeutic applications. IEEE Trans Biomed Eng. 2019;66(10):2704\u201318.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"6498","key":"8092_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1126\/science.368.6498.1408","volume":"368","author":"K Servick","year":"2020","unstructured":"Servick K. Hope grows for targeting the brain with ultrasound. Science. 2020;368(6498):1408\u20139.","journal-title":"Science"},{"issue":"3","key":"8092_CR12","doi-asserted-by":"publisher","first-page":"031003","DOI":"10.1088\/1741-2560\/13\/3\/031003","volume":"13","author":"O Naor","year":"2016","unstructured":"Naor O, Krupa S, Shoham S. Ultrasonic neuromodulation. J Neural Eng. 2016;13(3):031003.","journal-title":"J Neural Eng"},{"issue":"3","key":"8092_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0301-5629(00)00204-0","volume":"26","author":"SB Barnett","year":"2000","unstructured":"Barnett SB, Ter Haar GR, Ziskin MC, et al. International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine. Ultrasound Med Biol. 2000;26(3):355\u201366.","journal-title":"Ultrasound Med Biol"},{"issue":"26","key":"8092_CR14","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1056\/NEJMoa2016311","volume":"383","author":"R Mart\u00ednez-Fern\u00e1ndez","year":"2020","unstructured":"Mart\u00ednez-Fern\u00e1ndez R, M\u00e1\u00f1ez-Mir\u00f3 JU, Rodr\u00edguez-Rojas R, et al. Randomized trial of focused ultrasound subthalamotomy for Parkinson\u2019s disease. N Engl J Med. 2020;383(26):2501\u201313.","journal-title":"N Engl J Med"},{"issue":"12","key":"8092_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/jamaneurol.2017.3098","volume":"74","author":"AE Bond","year":"2017","unstructured":"Bond AE, Shah BB, Huss DS, et al. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial. JAMA Neurol. 2017;74(12):1412\u20138.","journal-title":"JAMA Neurol"},{"issue":"2","key":"8092_CR16","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3171\/2017.11.FOCUS17610","volume":"44","author":"SA Quadri","year":"2018","unstructured":"Quadri SA, Waqas M, Khan I, et al. High-intensity focused ultrasound: past, present, and future in neurosurgery. Neurosurg Focus. 2018;44(2):E16.","journal-title":"Neurosurg Focus"},{"issue":"3","key":"8092_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3171\/2016.11.JNS16976","volume":"128","author":"RF Dallapiazza","year":"2018","unstructured":"Dallapiazza RF, Timbie KF, Holmberg S, et al. Noninvasive neuromodulation and thalamic mapping with low-intensity focused ultrasound. J Neurosurg. 2018;128(3):875\u201384.","journal-title":"J Neurosurg"},{"issue":"2","key":"8092_CR18","doi-asserted-by":"publisher","first-page":"2251145","DOI":"10.1080\/07853890.2023.2251145","volume":"55","author":"YX Zhong","year":"2023","unstructured":"Zhong YX, Liao JC, Liu X, et al. Low intensity focused ultrasound: a new prospect for the treatment of Parkinson\u2019s disease. Ann Med. 2023;55(2):2251145.","journal-title":"Ann Med"},{"issue":"5","key":"8092_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2010.05.008","volume":"66","author":"Y Tufail","year":"2010","unstructured":"Tufail Y, Matyushov A, Baldwin N, et al. Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron. 2010;66(5):681\u201394.","journal-title":"Neuron"},{"issue":"3","key":"8092_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brs.2011.03.007","volume":"4","author":"A Bystritsky","year":"2011","unstructured":"Bystritsky A, Korb AS, Douglas PK, et al. A review of low-intensity focused ultrasound pulsation. Brain Stimul. 2011;4(3):125\u201336.","journal-title":"Brain Stimul"},{"issue":"6","key":"8092_CR21","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.brs.2018.08.013","volume":"11","author":"A Fomenko","year":"2018","unstructured":"Fomenko A, Neudorfer C, Dallapiazza RF, et al. Low-intensity ultrasound neuromodulation: an overview of mechanisms and emerging human applications. Brain Stimul. 2018;11(6):1209\u201317.","journal-title":"Brain Stimul"},{"issue":"1","key":"8092_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/cercor\/bhab201","volume":"32","author":"CY Sung","year":"2021","unstructured":"Sung CY, Chiang PK, Tsai CW, et al. Low-intensity pulsed ultrasound enhances neurotrophic factors and alleviates neuroinflammation in a rat model of Parkinson\u2019s disease. Cereb Cortex. 2021;32(1):176\u201385.","journal-title":"Cereb Cortex"},{"issue":"11","key":"8092_CR23","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1109\/TBME.2019.2899631","volume":"66","author":"H Zhou","year":"2019","unstructured":"Zhou H, Niu L, Xia X, et al. Wearable ultrasound improves motor function in an MPTP mouse model of Parkinson\u2019s disease. IEEE Trans Biomed Eng. 2019;66(11):3006\u201313.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"2","key":"8092_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ultrasmedbio.2021.10.001","volume":"48","author":"WS Song","year":"2022","unstructured":"Song WS, Sung CY, Ke CH, et al. Anti-inflammatory and neuroprotective effects of transcranial ultrasound stimulation on Parkinson\u2019s disease. Ultrasound Med Biol. 2022;48(2):265\u201374.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"8092_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2006;5(1):75\u201386.","journal-title":"Lancet Neurol"},{"key":"8092_CR26","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"11","key":"8092_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(08)70239-4","volume":"7","author":"D Berg","year":"2008","unstructured":"Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008;7(11):1044\u201355.","journal-title":"Lancet Neurol"},{"issue":"2","key":"8092_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7863\/jum.2012.31.2.191","volume":"31","author":"CL Go","year":"2012","unstructured":"Go CL, Frenzel A, Rosales RL, et al. Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system. J Ultrasound Med. 2012;31(2):191\u20136.","journal-title":"J Ultrasound Med"},{"key":"8092_CR29","first-page":"153","volume-title":"Recent developments in Parkinsons disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL, UPDRS program members. Unified Parkinsons disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinsons disease, vol. 2. Florham: Macmillan Healthcare Information; 1987. p. 153\u201363."},{"key":"8092_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mds.870090112","volume":"9","author":"P Martinez-Martin","year":"1994","unstructured":"Martinez-Martin P, Gil-Nagel A, Gracia LM, et al. Unified Parkinson\u2019s disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord. 1994;9:76\u201383.","journal-title":"Mov Disord"},{"issue":"4","key":"8092_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/apnr.2000.9231","volume":"13","author":"VC Pangman","year":"2000","unstructured":"Pangman VC, Sloan J, Guse L. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. Appl Nurs Res. 2000;13(4):209\u201313.","journal-title":"Appl Nurs Res"},{"key":"8092_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"8092_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.janxdis.2005.05.004","volume":"20","author":"OT Leyfer","year":"2006","unstructured":"Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck anxiety inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20(4):444\u201358.","journal-title":"J Anxiety Disord"},{"issue":"10","key":"8092_CR34","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00415-015-7839-8","volume":"262","author":"A Markser","year":"2015","unstructured":"Markser A, Maier F, Lewis CJ, et al. Deep brain stimulation and cognitive decline in Parkinson\u2019s disease: the predictive value of electroencephalography. J Neurol. 2015;262(10):2275\u201384.","journal-title":"J Neurol"},{"issue":"6","key":"8092_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11910-014-0448-6","volume":"14","author":"J Prodoehl","year":"2014","unstructured":"Prodoehl J, Burciu RG, Vaillancourt DE. Resting state functional magnetic resonance imaging in Parkinson\u2019s disease. Curr Neurol Neurosci Rep. 2014;14(6):448.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"8092_CR36","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/mds.20914","volume":"21","author":"A Schrag","year":"2006","unstructured":"Schrag A, Sampaio C, Counsell N, et al. Minimal clinically important change on the unified Parkinson\u2019s disease rating scale. Mov Disord. 2006;21(8):1200\u20137.","journal-title":"Mov Disord"},{"key":"8092_CR37","doi-asserted-by":"publisher","first-page":"h681","DOI":"10.1136\/bmj.h681","volume":"350","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P. Intention to treat analysis versus per protocol analysis of trial data. BMJ. 2015;350:h681.","journal-title":"BMJ"},{"issue":"9996","key":"8092_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"8","key":"8092_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2202721","volume":"388","author":"V Krishna","year":"2023","unstructured":"Krishna V, Fishman PS, Eisenberg HM, et al. Trial of globus pallidus focused ultrasound ablation in Parkinson\u2019s disease. N Engl J Med. 2023;388(8):683\u201393.","journal-title":"N Engl J Med"},{"issue":"1","key":"8092_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(17)30403-9","volume":"17","author":"R Mart\u00ednez-Fern\u00e1ndez","year":"2018","unstructured":"Mart\u00ednez-Fern\u00e1ndez R, Rodr\u00edguez-Rojas R, Del \u00c1lamo M, et al. Focused ultrasound subthalamotomy in patients with asymmetric Parkinson\u2019s disease: a pilot study. Lancet Neurol. 2018;17(1):54\u201363.","journal-title":"Lancet Neurol"},{"issue":"1","key":"8092_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/JPD-212810","volume":"12","author":"A Sinai","year":"2022","unstructured":"Sinai A, Nassar M, Sprecher E, et al. Focused ultrasound thalamotomy in tremor dominant Parkinson\u2019s disease: long-term results. J Parkinsons Dis. 2022;12(1):199\u2013206.","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"8092_CR42","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1121\/1.1410964","volume":"110","author":"M Hayner","year":"2001","unstructured":"Hayner M, Hynynen K. Numerical analysis of ultrasonic transmission and absorption of oblique plane waves through the human skull. J Acoust Soc Am. 2001;110(6):3319\u201330.","journal-title":"J Acoust Soc Am"},{"issue":"9","key":"8092_CR43","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1088\/0031-9155\/51\/9\/013","volume":"51","author":"PJ White","year":"2006","unstructured":"White PJ, Clement GT, Hynynen K. Local frequency dependence in transcranial ultrasound transmission. Phys Med Biol. 2006;51(9):2293\u2013305.","journal-title":"Phys Med Biol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08092-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T08:05:56Z","timestamp":1713773156000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08092-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8092"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08092-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has been approved by the Ethics Committee of Shanghai Sixth People\u2019s Hospital (approval No. 2022-023). The research registry number is ChiCTR2100052093 at\n                      \n                      . All participants are required to provide written consent prior to their participation. Ethics approval is provided in Additional file\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors, their immediate families, and any research foundation with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"275"}}